What changed 10-K

Item 2. Properties

2025-02-28 compared with 2024-02-29 · 6 added, 6 removed, 2 unchanged (86% of the section changed)

Properties and Facilities

and Facilities

lease a 14,507 square foot manufacturing facility in Irvine, California under a lease that expires on September 30, 2027.

Our facility is designed expressly

for the manufacture of biologic vascular grafts and is equipped for research and development, prototype fabrication, cGMP

manufacturing and shipping for Class III medical devices, including biologic cardiovascular devices.

is designed expressly for the manufacture of biologic vascular grafts and is equipped for research and development, prototype fabrication,

cGMP manufacturing and shipping for Class III medical devices, including biologic cardiovascular devices.

We believe that our facilities

are sufficient for the near future as there is present capacity to manufacture up to approximately 24,000 venous valves per year to

meet potential market demands.

are sufficient for the near future as there is present capacity to manufacture up to approximately 24,000 venous valves per year to meet

potential market demands.

and Safety Disclosure

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.